Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
My Quest to Mordor: A 7-Year Journey to Find a Drug Against Aging
What it takes to develop one drug that might give everyone a chance at a longer life, and whether a decade of my life spent on it was worth it
Nov 1
•
Alex Zhavoronkov, PhD
48
7
2
October 2026
The Power of Love in Longevity
Relationships and purpose track with longer lives, but women often spend their last years alone. Longevity biotech can close this gap.
Oct 20
•
Alex Zhavoronkov, PhD
38
6
1
The ChatGPT Moment in Longevity Biotechnology: Three Biological Age Reduction Reveals From Clinical Data
By Alex Zhavoronkov | Forever.ai
Oct 12
•
Alex Zhavoronkov, PhD
41
6
3
September 2026
The UAE Can Become the Longevity Capital of the World
Longevity is usually is split into Longevity Medicine, things you can do today to live longer better, and Longevity Biotechnology, discovery of novel…
Sep 6
•
Alex Zhavoronkov, PhD
31
8
4
August 2026
The Naked Emperors of AI Drug Discovery: How Shoemakers Without Shoes Get Attention and Deals and Will the Bubble Burst?
In the private market for AI drug discovery there may be in a bubble
Aug 31
•
Alex Zhavoronkov, PhD
48
5
9
Longevity Is Being Democratized. Here's One of the Largest Rollouts
Notes from Boston to Shanghai, and why the Ping An Healthcare Longevity launch is a big deal
Aug 19
•
Alex Zhavoronkov, PhD
44
5
6
July 2026
The First Nobel Prize for Longevity: Who and When Will Get the Nobel Prize for GLP-1?
After Joel Habener’s death, the frontier AI models I asked now converge on the same core forecast: GLP-1 will receive the Nobel Prize in Physiology or…
Jul 28
•
Alex Zhavoronkov, PhD
37
3
2
Can We Make Perfumes More Useful?
When odorless insect repellents have higher or comparable safety profile to the common perfume ingredients, why not combine them?
Jul 26
•
Alex Zhavoronkov, PhD
28
5
1
The Unsung Heroes of the Biotechnology Revolution: Who Made Australia the Top Destination for Clinical Trials and Biomedical Research?
Australia built the fastest, most trustworthy early-clinical system in the world through decades of unglamorous policy work. The world should know its…
Jul 21
•
Alex Zhavoronkov, PhD
31
1
Potential Longevity Therapeutics: TEAD inhibitors and their role in cancer, fibrosis, and aging
Why a safe, balanced pan-TEAD inhibitor may be a pipeline in a product spanning oncology, fibrosis, and aging
Jul 6
•
Alex Zhavoronkov, PhD
32
2
June 2026
AI Drug Discovery Dreams: How Fast Can an AI-Discovered Drug Be Approved?
What can we learn from the fastest novel target/novel molecule discovery to FDA approval stories to date and should we expect miracles from AI?
Jun 30
•
Alex Zhavoronkov, PhD
44
9
3
Can We Accelerate Drug Discovery and Longevity Research by Replacing/Augmenting IND-Enabling Studies With Human Volunteers in Emerging…
Big Idea: Can UAE, KSA, India, and Other Countries Aspiring to Enter The Biotechnology Industry Leapfrog Established Players by Replacing GLP Animal…
Jun 26
•
Alex Zhavoronkov, PhD
33
1
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts